BRCA2 (pSer3291) [P-CS-4]Western blot analysis of Hela cells either treated (LH) or untreated with nocodazole prior to analysis of total lysate either with indicated phospho-specific antibody or anti-BRCA2 antibody [P-CS-4] by immunoblotting blotting
WHO ARE IMMUQUEST?
Adam Bernard (a Serotec founder) and partners set up Immuquest Ltd in 2002. From our headoffice in North Yorkshire, our QUEST is to work in partnership with the scientific community WORLDWIDE to deliver a unique range of quality antibodies for use in existing and emerging areas of scientific interest. Everything we do is undertaken with the needs of our research customers in mind. We sell DIRECTLY to scientists all over the world using international couriers FedEx and UPS. We also have an extensive group of companies who distribute our products in every Continent. We offer comprehensive customer service and support worldwide and peace of mind with our PRODUCT ASSURANCE GUARANTEE. read more ›